Eli Lilly and Novo Want to Shake off Ozempic Copycats. Are They Ready to Meet Demand?
The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...
Novo Nordisk readies trial results for next-generation weight-loss drug
The headline trial results will be closely monitored by pharmaceutical industry experts. Shares in Novo Nordisk, which ...
Medpage Today on MSN23h
Tirzepatide Officially Puts GLP-1 Meds on the Map for Obesity-Related Heart Failure
CHICAGO -- A long-acting GIP/GLP-1 receptor agonist conferred significant clinical benefit for people with obesity and ...
pharmaphorum20h
Lilly's Alzheimer's drug gets UK nod, but no NHS funding
Lilly said in a statement that there are 982,000 ... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.